Short-wavelength automated perimetry

Ophthalmology Clinics of North America

Volumn 16, Issue 2, 2003, Pages 227-236

  Racette, Lyne ^a   Sample, Pamela A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; CLINICAL RESEARCH; COLOR VISION; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; FUTUROLOGY; GLAUCOMA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MIGRAINE; MULTIPLE SCLEROSIS; ONSET AGE; OPTIC NERVE DISEASE; PERIMETRY; PREDICTION; PRIORITY JOURNAL; PSYCHOPHYSICS; RETINA MACULOPATHY; REVIEW; SHORT WAVELENGTH AUTOMATED PERIMETRY; STANDARD; VALIDATION PROCESS; VISION; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 0037946766     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(03)00010-5     Document Type: Review

References (56)

1. Adams AJ, Rodic R, Husted R, Stamper R. Spectral sensitivity and color discrimination changes in glaucoma and glaucoma-suspect patients. Invest Ophthalmol Vis Sci 1982;23:516-24.
2. Drance SM, Lakowski R, Schulzer M, Douglas GR. Acquired color vision changes in glaucoma: use of 100-hue test and Pickford anomaloscope as predictors of glaucomatous field change. Arch Ophthalmol 1981;99:829-31.
3. Flammer J, Drance SM. Correlation between color vision scores and quantitative perimetry in suspected glaucoma. Arch Ophthalmol 1984;102:38-9.
4. Hamill TR, Post RB, Johnson CA, Keltner JL. Correlation of color vision deficits and observable changes in the optic disc in a population of ocular hypertensives. Arch Ophthalmol 1984;102:1637-9.
5. Dacey DM, Lee BB. The "blue-on" opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature 1994;367:731-5.
6. Martin PR, White AJ, Goodchild AK, Wilder HD, Sefton AE. Evidence that blue-on cells are part of the third geniculocortical pathway in primates. Eur J Neurosci 1997;9:1536-41.
7. Yücel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000;118:378-84.
8. Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci 2000;41:1783-90.
9. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma 1994;3(suppl):532-44.
10. Sample PA, Johnson CA, Haegerstrom-Portnoy G, Adams AJ. Optimum parameters for short-wavelength automated perimetry. J Glaucoma 1996;5:375-83.
11. Åsman P, Heijl A. Glaucoma Hemifield Test: automated visual field evaluation. Arch Ophthalmol 1992;110:812-9.
12. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 1993;111:645-50.
13. Sample PA, Taylor JD, Martinez GA, Lusky M, Weinreb RN. Short-wavelength color visual fields in glaucoma suspects at risk. Am J Ophthalmol 1993;115:225-33.
14. Johnson CA, Brandt JD, Khong AM, Adams AJ. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes: initial baseline results. Arch Ophthalmol 1995;113:70-6.
15. Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, Gordon MO. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study - Ocular Hypertension Treatment Study Group. Arch Ophthalmol 2000;118:1187-94.
16. Demirel S, Johnson CA. Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol 2001;131:709-15.
17. Sample PA, Weinreb RN. Progressive color visual field loss in glaucoma. Invest Ophthalmol Vis Sci 1992;33:2068-71.
18. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol 1993;111:651-6.
19. Sample PA, Weinreb RN. Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1990;31:1869-75.
20. Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 2002;47:158-73.
21. Girkin CA, Emdadi A, Sample PA, Blumenthal EZ, Lee AC, Zangwill LM, et al. Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping. Arch Ophthalmol 2000;118:1231-6.
22. Mansberger SL, Sample PA, Zangwill L, Weinreb RN. Achromatic and short-wavelength automated perimetry in patients with glaucomatous large cups. Arch Ophthalmol 1999;117:1473-7.
23. Larrosa JM, Polo V, Pablo L, Pinilla I, Fernandez FJ, Honrubia FM. Short-wavelength automated perimetry and neuroretinal rim area. Eur J Ophthalmol 2000;10:116-20.
24. Yamagishi N, Anton A, Sample PA, Zangwill L, Lopez A, Weinreb RN. Mapping structural damage of the optic disc to visual field defect in glaucoma. Am J Ophthalmol 1997;123:667-76.
25. Mok KH, Lee VW. Nerve fiber analyzer and short-wavelength automated perimetry in glaucoma suspects: a pilot study. Ophthalmology 2000;107:2101-4.
26. Polo V, Abecia E, Pablo LE, Pinilla I, Larrosa JM, Honrubia FM. Short-wavelength automated perimetry and retinal nerve fiber layer evaluation in suspected cases of glaucoma. Arch Ophthalmol 1998;116:1295-8.
27. Ugurlu S, Hoffman D, Garway-Heath DF, Caprioli J. Relationship between structural abnormalities and short-wavelength perimetric defects in eyes at risk of glaucoma. Am J Ophthalmol 2000;129:592-8.
28. Teesalu P, Vihanninjoki K, Airaksinen PJ, Tuulonen A, Laara E. Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements. Invest Ophthalmol Vis Sci 1997;38:2452-9.
29. Johnson CA. Recent developments in automated perimetry in glaucoma diagnosis and management. Curr Opin Ophthalmol 2002;13:77-84.
30. Anderson AJ, Patella VM. Automated static perimetry. 2nd edition. St. Louis, MO: CV Mosby; 1999.
31. Johnson CA, Adams AJ, Lewis RA. Evidence for a neural basis of age-related visual field loss in normal observers. Invest Ophthalmol Vis Sci 1989;30:2056-64.
32. Moss ID, Wild JM, Whitaker DJ. The influence of age-related cataract on blue-on-yellow perimetry. Invest Ophthalmol Vis Sci 1995;36:764-73.
33. Sample PA, Esterson FD, Weinreb RN, Boynton RM. The aging lens: in vivo assessment of light absorption in 84 human eyes. Invest Ophthalmol Vis Sci 1988;29:1306-11.
34. Johnson CA, Adams AJ, Twelker JD, Quigg JM. Age-related changes in the central visual field for short-wavelength-sensitive pathways. J Opt Soc Am A 1988;5:2131-9.
35. Sample PA. Short-wavelength automated perimetry: its role in the clinic and for understanding ganglion cell function. Prog Retinal Eye Res 2000;19:369-83.
36. Wild JM. Short wavelength automated perimetry. Acta Ophthalmol Scand 2001;79:546-59.
37. Johnson CA, Howard DL, Marshall D, Shu H. A non-invasive video-based method for measuring lens transmission properties of the human eye. Optom Vis Sci 1993;70:944-55.
38. Sample PA, Martinez GA, Weinreb RN. Short-wavelength automated perimetry without lens density testing. Am J Ophthalmol 1994;118:632-41.
39. Kwon YH, Park HJ, Jap A, Ugurlu S, Caprioli J. Test-retest variability of blue-on-yellow perimetry is greater than white-on-white perimetry in normal subjects. Am J Ophthalmol 1998;126:29-36.
40. Sample PA, Cook JN, Weinreb RN. Variability and sensitivity of short-wavelength color visual fields in normal and glaucoma eyes. In: Digest of Topical Meeting on Noninvasive Assessment of the Visual System. Technical Digest Series, volume 3. Washington, DC: Optical Society of America; 1993. p. 292-5.
41. Wild JM, Cubbidge RP, Pacey IE, Robinson R. Statistical aspects of the normal visual field in short-wavelength automated perimetry. Invest Ophthalmol Vis Sci 1998;39:54-63.
42. Hutchings N, Hosking SL, Wild JM, Flanagan JG. Long-term fluctuation in short-wavelength automated perimetry in glaucoma suspects and glaucoma patients. Invest Ophthalmol Vis Sci 2001;42:2332-7.
43. Blumenthal EZ, Sample PA, Zangwill L, Lee AC, Kono Y, Weinreb RN. Comparison of long-term variability for standard and short-wavelength automated perimetry in stable glaucoma patients. Am J Ophthalmol 2000;129:309-13.
44. Bengtsson B, Heijl A. Inter-subject variability and normal limits of the SITA Standard, SITA Fast, and the Humphrey Full Threshold computerized perimetry strategies: SITA STATPAC. Acta Ophthalmol Scand 1999;77:125-9.
45. Sample PA, Johnson CA. Functional assessment of glaucoma. J Glaucoma 2001;10:S49-52.
46. Cubbidge RP, Wild JM. The influences of stimulus wavelength and eccentricity on short-wavelength pathway isolation in automated perimetry. Ophthalmic Physiol Opt 2001;21:1-8.
47. Demirel S, Johnson CA. Isolation of short-wavelength sensitive mechanisms in normal and glaucomatous visual field regions. J Glaucoma 2000;9:63-73.
48. Sample PA, Plummer DJ, Weinreb RN. Standard achromatic automated perimetry vs. short-wavelength automated perimetry for following glaucoma. In: Krieglstein GK, editor. Glaucoma update. Köln: Kaden Verlag; 1995. p. 197-216.
49. Nomura R, Terasaki H, Hirose H, Miyake Y. Blue-on-yellow perimetry to evaluate S cone sensitivity in diabetics. Ophthalmic Res 2000;32:69-72.
50. Remky A, Arend O, Hendricks S. Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest Ophthalmol Vis Sci 2000;41:274-81.
51. Hudson C, Flanagan JG, Turner GS, Chen HC, Young LB, McLeod D. Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema. Diabetologia 1998;41:918-28.
52. Hudson C, Flanagan JG, Turner GS, Chen HC, Young LB, McLeod D. Influence of laser photocoagulation for clinically significant diabetic macular oedema (DMO) on short-wavelength and conventional automated perimetry. Diabetologia 1998;41:1283-92.
53. Plummer DJ, Sample PA, Arevalo JF, Grant I, Quiceno JI, Dua R, et al. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol 1996;122:542-9.
54. McKendrick AM, Cioffi GA, Johnson CA. Short-wavelength sensitivity deficits in patients with migraine. Arch Ophthalmol 2002;120:154-61.
55. Keltner JL, Johnson CA. Short-wavelength automated perimetry in neuro-ophthalmologic disorders. Arch Ophthalmol 1995;113:475-81.
56. Fujimoto N, Adachi-Usami E. Use of blue-on-yellow perimetry to demonstrate quadrantanopia in multiple sclerosis. Arch Ophthalmol 1998;116:828-9.